Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Vicente VillanuevaCédric LaloyauxWendyl J D'SouzaEdward FaughtPavel KleinMarkus ReuberFelix RosenowJavier Salas-PuigVictor Soto InsugaAdam StrzelczykJerzy P SzaflarskiChris ChinnTony DanielsFlorin FloricelDavid FriesenVeronica SenderskyHervé BessonBernhard J SteinhoffPublished in: CNS drugs (2023)
This pooled analysis using data from a variety of real-world settings suggests BRV is effective and well tolerated in routine clinical practice in a highly drug-resistant patient population.